{"url":"https://etfiq.com/holdings/asnd/","section":"holdings","title":"ETFs That Hold Ascendis Pharma A/S (ASND) | ETFIQ","description":"61 thematic and core ETFs hold Ascendis Pharma A/S (ASND). MEDI holds the most, at 13.61% of the fund on Jul 31, 2026. Weights and dates for every holder.","as_of":"Nov 5, 2026","structured_data":[{"@type":"Dataset","@id":"https://etfiq.com/holdings/asnd#data","name":"ETFs holding Ascendis Pharma A/S","description":"Every US listed ETF that holds Ascendis Pharma A/S, with each fund\u2019s published weight and filing date.","creator":{"@id":"https://etfiq.com/#org"},"isAccessibleForFree":true,"variableMeasured":["Share of fund","Holdings filing date"],"license":"https://etfiq.com/license/","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/alternatives.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/core.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/crypto.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/funds.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/income.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/leverage.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/thematic.json"}]},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Which ETFs hold Ascendis Pharma A/S?","acceptedAnswer":{"@type":"Answer","text":"61 thematic and core ETFs hold Ascendis Pharma A/S, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are MEDI at 13.61% of the fund on Jul 31, 2026, FPXE at 6.06% of the fund on Nov 3, 2026 and AFOS at 3.47% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Holdings","item":"https://etfiq.com/holdings/"},{"@type":"ListItem","position":3,"name":"ASCENDIS PHARMA A/S","item":"https://etfiq.com/holdings/asnd/"}]},{"@type":"WebPage","name":"ETFs That Hold Ascendis Pharma A/S (ASND)","description":"61 thematic and core ETFs hold Ascendis Pharma A/S (ASND). MEDI holds the most, at 13.61% of the fund on Jul 31, 2026. Weights and dates for every holder.","url":"https://etfiq.com/holdings/asnd/","dateModified":"2026-11-04","isPartOf":{"@type":"WebSite","name":"ETFIQ","url":"https://etfiq.com"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".lede",".faq"]},"publisher":{"@id":"https://etfiq.com/#org"}}],"characters":6401,"truncated":false,"content":"ETFIQ / Holdings / ASCENDIS PHARMA A/S \n \n ETFs that hold Ascendis Pharma A/S\n 61 thematic and core ETFs hold Ascendis Pharma A/S , by holdings dated Jun 30, 2026 to Nov 3, 2026 . MEDI holds the most, at 13.61% of the fund on Jul 31, 2026 . The next largest are FPXE (6.06%) and AFOS (3.47%). \n 1 income and other fund on it is listed below.\n Thematic and core funds that hold it\n Fund Name Share of the fund Holdings filed Asset \n MEDI Harbor Health Care ETF 13.61% Jul 31, 2026 Equity \n FPXE First Trust IPOX Europe Equity Opportunities ETF 6.06% Nov 3, 2026 Equity \n AFOS ARS Focused Opportunities Strategy ETF 3.47% Aug 31, 2026 Equity \n AADR AdvisorShares Dorsey Wright ADR ETF 3.19% Jun 30, 2026 Equity \n FDG American Century Focused Dynamic Growth ETF 2.72% Aug 31, 2026 Equity \n SQS Sapient Quality Select ETF 2.63% Jul 31, 2026 Equity \n EXUS Nomura Focused International Core ETF 2.21% Jun 30, 2026 Equity \n FMED Fidelity Disruptive Medicine ETF 1.97% Aug 31, 2026 Equity \n TMED T. Rowe Price Health Care ETF 1.60% Jun 30, 2026 Equity \n BBP Virtus Biotech ETF 1.54% Jul 31, 2026 Equity \n FXH First Trust Health Care AlphaDEX Fund 1.38% Nov 3, 2026 Equity \n TCAF T. Rowe Price Capital Appreciation Equity ETF 1.26% Jun 30, 2026 Equity \n FFOG Franklin Focused Growth ETF 1.12% Jun 30, 2026 Equity \n ILDR First Trust Innovation Leaders ETF 1.07% Nov 3, 2026 Equity \n IBB iShares Biotechnology ETF 1.06% Nov 3, 2026 Equity \n IBBQ Invesco Nasdaq Biotechnology ETF 0.99% Nov 3, 2026 Equity \n MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF 0.89% Aug 31, 2026 Equity \n QQQJ Invesco NASDAQ Next Gen 100 ETF 0.78% Nov 3, 2026 Equity \n IWP iShares Russell Mid-Cap Growth ETF 0.38% Nov 3, 2026 Equity \n TMSL T. Rowe Price Small-Mid Cap ETF 0.35% Jun 30, 2026 Equity \n WDAI Pacer S&P World 3AI Top 300 ETF 0.33% Jul 31, 2026 Equity \n ESIM Eventide International ETF 0.29% Jul 31, 2026 Equity \n IDHQ Invesco S&P International Developed Quality ETF 0.26% Nov 3, 2026 Equity \n MSLC Morgan Stanley Pathway Large Cap Equity ETF 0.25% Aug 31, 2026 Equity \n TNXT T. Rowe Price Innovation Leaders ETF 0.23% Jun 30, 2026 Equity \n IYH iShares U.S. Healthcare ETF 0.19% Nov 3, 2026 Equity \n SMMD iShares Russell 2500 ETF 0.19% Nov 3, 2026 Equity \n QQHG Invesco QQQ Hedged Advantage ETF 0.15% Nov 3, 2026 Equity \n RUSC Russell Investments U.S. Small Cap Equity ETF 0.12% Jun 30, 2026 Equity \n REMC Columbia Research Enhanced Mid Cap ETF 0.12% Jun 30, 2026 Equity \n IWR iShares Russell Mid-Cap ETF 0.10% Nov 3, 2026 Equity \n EQAL Invesco Russell 1000 Equal Weight ETF 0.09% Nov 3, 2026 Equity \n GSWO Goldman Sachs ActiveBeta World Equity ETF 0.09% Aug 31, 2026 Equity \n IQSI NYLIM Candriam International Equity ETF 0.08% Jul 31, 2026 Equity \n VFMO Vanguard U.S. Momentum Factor ETF 0.08% Sep 30, 2026 Equity \n GSID Goldman Sachs MarketBeta International Equity ETF 0.06% Aug 31, 2026 Equity \n MNZL Manzil Russell Halal USA Broad Market ETF 0.05% Jul 31, 2026 Equity \n VDG Vanguard Developed Markets ex-US Growth Index ETF 0.05% Sep 30, 2026 Equity \n BKIE BNY Mellon International Equity ETF 0.04% Jul 31, 2026 Equity \n GGUS Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF 0.04% Aug 31, 2026 Equity \n IWF iShares Russell 1000 Growth ETF 0.04% Nov 3, 2026 Equity \n SPDW State Street SPDR Portfolio Developed World ex-US ETF 0.04% Nov 3, 2026 Equity \n VDV Vanguard Developed Markets ex-US Value Index ETF 0.04% Sep 30, 2026 Equity \n ONEQ Fidelity Nasdaq Composite Index ETF 0.04% Aug 31, 2026 Equity \n VONG Vanguard Russell 1000 Growth ETF 0.03% Sep 30, 2026 Equity \n GXUS Goldman Sachs MarketBeta Total International Equity ETF 0.03% Aug 31, 2026 Equity \n AVUQ Avantis U.S. Quality ETF 0.03% Nov 2, 2026 Equity \n ONEO State Street SPDR Russell 1000 Momentum Focus ETF 0.03% Nov 3, 2026 Equity \n IWB iShares Russell 1000 ETF 0.02% Nov 3, 2026 Equity \n IWV iShares Russell 3000 ETF 0.02% Nov 3, 2026 Equity \n RECS Columbia Research Enhanced Core ETF 0.02% Jul 31, 2026 Equity \n VONE Vanguard Russell 1000 ETF 0.02% Sep 30, 2026 Equity \n VTHR Vanguard Russell 3000 ETF 0.02% Sep 30, 2026 Equity \n OMFL Invesco Russell 1000 Dynamic Multifactor ETF 0.01% Nov 3, 2026 Equity \n VT Vanguard Total World Stock Index ETF 0.01% Sep 30, 2026 Equity \n DEUS Xtrackers Russell US Multifactor ETF 0.01% Aug 31, 2026 Equity \n IWS iShares Russell Mid-Cap Value ETF 0.01% Nov 3, 2026 Equity \n FBCG Fidelity Blue Chip Growth ETF 0.01% Jul 31, 2026 Equity \n REVS Columbia Research Enhanced Value ETF Jul 31, 2026 Equity \n VONV Vanguard Russell 1000 Value ETF Sep 30, 2026 Equity \n IWD iShares Russell 1000 Value ETF Nov 3, 2026 Equity \n Income and other funds that hold it\n Fund Name Share of the fund Holdings filed Category \n TCAL T. Rowe Price Capital Appreciation Premium Income ETF 0.56% Jun 30, 2026 Income \n What this counts\n Ascendis Pharma A/S (ticker ASND, listed in DK) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund\u2019s N-PORT asset type. A fund holding only the company\u2019s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.\n Each row shows the date the fund last filed.\n Look up another company .\n Questions people ask\n Which ETFs hold Ascendis Pharma A/S? 61 thematic and core ETFs hold Ascendis Pharma A/S, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are MEDI at 13.61% of the fund on Jul 31, 2026, FPXE at 6.06% of the fund on Nov 3, 2026 and AFOS at 3.47% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart. \n Cite this page. ETFIQ, ETFs holding ASCENDIS PHARMA A/S, data as of Nov 5, 2026. https://etfiq.com/holdings/asnd/ Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data .\n Other forms Plain ETFIQ, ETFs holding ASCENDIS PHARMA A/S, data as of Nov 5, 2026. https://etfiq.com/holdings/asnd/ APA ETFIQ. (Nov 5, 2026). ETFs holding ASCENDIS PHARMA A/S. Retrieved from https://etfiq.com/holdings/asnd/ Markdown [ETFs holding ASCENDIS PHARMA A/S (ETFIQ, Nov 5, 2026)](https://etfiq.com/holdings/asnd/)","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","license_text":"Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.","citation":"ETFIQ, ETFs holding ASCENDIS PHARMA A/S, data as of Nov 5, 2026. https://etfiq.com/holdings/asnd/"}